Characterisation of T Cell Receptor Repertoire in Non-small Cell Lung Cancer Patients Treated with Immunotherapy

被引：0

作者：

Goni, A. S. ^{[1
]}

Ramirez, A. ^{[2
]}

Cruellas, M. ^{[3
]}

Esteban, P. ^{[2
]}

Galvez, E. M. ^{[4
]}

Gascon-Ruiz, M. ^{[5
]}

Isla, D. ^{[5
]}

Martinez-Lostao, L. ^{[2
]}

Ocariz, M. ^{[5
]}

Pano, J. R. ^{[5
]}

Pardo, J. ^{[2
]}

Quilez, E. ^{[5
]}

Torres-Ramon, I. ^{[5
]}

Yubero, A. ^{[5
]}

Zapata, M. ^{[5
]}

Lastra, R. ^{[5
]}

机构：

[1] Hosp Clin Univ Lozano Blesa, Zaragoza, Spain

[2] Aragon Hlth Res Inst, Zaragoza, Spain

[3] Hosp Valle De Hebron, Barcelona, Spain

[4] CSIC, Inst Carboquim, Zaragoza, Spain

[5] Hosp Clin Lozano Blesa, Zaragoza, Spain

来源：

JOURNAL OF THORACIC ONCOLOGY | 2022年 / 17卷 / 09期

关键词：

LUNG CANCER; BIOMARKER; T-CELL RECEPTOR;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

EP16.01-03

引用

页码：S570 / S571

页数：2

共 50 条

[21] Dendritic cell immunotherapy in non-small cell lung cancer
Choi, Y.
Chung, J.
Shin, H.
Cho, G.
Sohn, C.
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
[22] T-Cell Receptor Repertoire Profiling as a Predictive Biomarker for Immunotherapy in Unresectable Stage III Non-small Cell Lung (NSCLC)
Trachu, N.
Iemwimangsa, N.
Anantaya, D.
Lumjiaktase, P.
Teoh, V. -H.
Oranratnachai, S.
Thamrongjirapa, T.
Khiewngam, K.
Monnamo, N.
Sanvarinda, P.
Incharoen, P.
Charoenyingwattana, A.
Chantratita, W.
Reungwetwattana, T.
JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S445 - S445
[23] Clinical value of pre-treatment T-cell receptors (TCR) repertoire in non-small cell lung cancer (NSCLC) patients treated with single agent immunotherapy
Abed, A.
Calapre, L.
Bowyer, S.
Millward, M.
Gray, E. S.
ANNALS OF ONCOLOGY, 2021, 32 : S1344 - S1344
[24] EVALUATION OF A COMPOSITE IMMUNOTHERAPY SIGNATURE IN NON-SMALL CELL LUNG CANCER PATIENTS TREATED WITH ATEZOLIZUMAB
Tolba, Khaled
Gandara, David
Montesion, Meagan
Nabet, Barzin
Srivastava, Minu
Albacker, Lee
Redman, Mary
Kozono, David
Cummings, Craig
Herbst, Roy
Shames, David
Fabrizio, David
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A611 - A611
[25] Incidence of clinically relevant hyperglycaemia in patients with non-small cell lung cancer treated with immunotherapy
Farag, S.
Moore, B.
Mulla, K.
Yousaf, N.
Popat, S.
Morganstein, D.
ANNALS OF ONCOLOGY, 2022, 33 (07) : S1081 - S1081
[26] Pretreatment predictive score for metastatic non-small cell lung cancer patients treated with immunotherapy
Musaelyan, A.
Moiseyenko, F.
Emileva, T.
Oganesyan, A. P.
Urtenova, M.
Odintsova, S.
Chistyakov, I.
Akopov, A.
Orlov, S.
JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (04) : S77 - S77
[27] Body Composition in Advanced Non-Small Cell Lung Cancer Treated With Immunotherapy
Chaunzwa, Tafadzwa L.
Qian, Jack M.
Li, Qin
Ricciuti, Biagio
Nuernberg, Leonard
Johnson, Justin W.
Weiss, Jakob
Zhang, Zhongyi
MacKay, Jamie
Kagiampakis, Ioannis
Bikiel, Damian
Di Federico, Alessandro
Alessi, Joao V.
Mak, Raymond H.
Jacob, Etai
Awad, Mark M.
Aerts, Hugo J. W. L.
JAMA ONCOLOGY, 2024, 10 (06) : 773 - 783
[28] T cell repertoire analysis of non-small cell lung cancer patients treated with neoadjuvant nivolumab alone or in combination with ipilimumab (NEOSTAR trial).
Reuben, Alexandre
Zhang, Jianjun
Lin, Heather Y.
Little, Latasha
Gumbs, Curtis
Tran, Hai T.
Wang, Linghua
Haymaker, Cara L.
Mehran, Reza J.
Rice, David C.
Walsh, Garrett L.
Lee, J. Jack
Wistuba, Ignacio Ivan
Swisher, Stephen
Vaporciyan, Ara A.
Futreal, Andrew
Sepesi, Boris
Heymach, John
Gibbons, Don Lynn
Cascone, Tina
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[29] Neoadjuvant immunotherapy in patients with resectable non-small cell lung cancer
Broderick, Stephen R.
Bott, Matthew J.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2019, 158 (05): : 1471 - 1474
[30] CIK Immunotherapy and Non-small Cell Lung Cancer in Geriatric Patients
Wang, X.
Zhu, Q.
Lu, L. Q.
Wu, G. Q.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2015, 63 : S357 - S357

← 1 2 3 4 5 →